BioSpace News Archive

The 2019 C3-Erba Verde Group Hemp & CBD Summit, is pleased to announce this important event, “Transforming Hemp to Healthcare and CBD to Commerce.”

Medical Marijuana, Inc. (OTC:MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that products from the Company’s major investment company AXIM® Biotechnologies, Inc.

Remedy, a provider of transparently priced and easily-accessible healthcare services, announced today that it has raised $10 million in Series A financing to support the company’s ongoing rapid growth, expand its technology platform and enhance its business offering for self-funded employers.

Livongo to Push Health Nudges to Members on Apple Watch, Fitbit, and Samsung Devices

This award recognized the commitment of Bio-Techne’s team in China to providing comprehensive support and reliable products and services for the Chinese Biotechnology industry.

Hired Leigh Dallow to lead business development efforts in the Eastern United States, bringing on an established business development executive in the biotech industry.

UCSF recently honored a physician alumna for creating the very first commercially successful wearable breast pump, according to Dao Health, the company she co-founded that brought her idea to life.

Cognito Therapeutics is a clinical-stage medical device company developing non-invasive neurostimulation therapies for neurodegenerative disorders such as Alzheimer’s disease

The 2019 report documents how, over the last three years, an overall culture of sustainability resulted in an 8% reduction in the company’s carbon-to-revenue footprint.

Itamar Medical’s (NASDAQ: ITMR) (TASE: ITMR) revolutionary technology enables cardiologists to make better decisions and results in 30% assumed revenue growth by the end of 2019; Itamar Medical has a $6.8B addressable market with limited competition; we start our coverage with a price target of 1.55 NIS.